As of November 2024, Kunming Longjin Pharmaceutical has a market cap of $114.26M. This makes Kunming Longjin Pharmaceutical the world's 20529th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $295.25M | -47.80% |
2023 | $565.62M | -10.15% |
2022 | $629.54M | -31.00% |
2021 | $912.35M | 92.48% |
2020 | $473.99M | -34.89% |
2019 | $727.96M | 129.82% |
2018 | $316.75M | -41.36% |
2017 | $540.17M | -42.57% |
2016 | $940.63M | -22.71% |
2015 | $1.22B | - |